Can fondaparinux be used for DVT?

Fondaparinux is approved in Europe and the US for the treatment of acute venous thromboembolism (VTE), including both deep vein thrombosis (DVT) and pulmonary embolism (PE), when used in conjunction with warfarin.

Table of Contents

Does fondaparinux inhibit thrombin?

Fondaparinux (Arixtra) is a synthetic anticoagulant based on the pentasaccharide sequence that makes up the minimal antithrombin (AT) binding region of heparin. Similar to low molecular weight heparins, it is an indirect inhibitor of factor Xa, but it does not inhibit thrombin at all.

Does fondaparinux bind to antithrombin?

Fondaparinux selectively binds to antithrombin III, thereby potentiating the innate neutralization of activated factor X (Factor Xa) by antithrombin. Neutralization of Factor Xa inhibits its activity and interrupts the blood coagulation cascade, thereby preventing thrombin formation and thrombus development.

How is fondaparinux different from heparin?

Fondaparinux (Arixtra) is an anticoagulant that shares the same pentasaccharide sequence as UFH and LMWH for the binding to antithrombin, however it has no extra chain and thus, is not considered a heparin product. It is also known to not cause HIT, as seen with UFH and LMWH.

Does fondaparinux affect INR?

At the 2.5 mg dose, Arixtra does not affect routine coagulation tests such as activated partial thromboplastin time (aPTT), activated clotting time (ACT) or prothrombin time (PT)/International Normalised Ratio (INR) tests in plasma, or bleeding time.

Does fondaparinux increase INR?

Arixtra neither influenced the INR activity of warfarin, nor the bleeding time under acetyl salicylic acid or piroxicam treatment. Bleeding risk is increased with concomitant administration of Arixtra and agents that may enhance the risk of hemorrhage.

What is the difference between fondaparinux and enoxaparin?

Fondaparinux is a factor Xa inhibitor and does not inhibit thrombin (IIa) [8]. Enoxaparin on the other hand, binds to antithrombin to form a complex molecule that can irreversibly inactivate clotting factor Xa and it has less activity against thrombin [9]. This is how these two anticoagulants work.

Why is Fondaparinux contraindicated in bacterial endocarditis?

Fondaparinux is contraindicated in patients with bacterial endocarditis due to increased risk of bleeding.

What is the difference between enoxaparin and Fondaparinux?

What is the mechanism of action of fondaparinux?

Mechanism of action The antithrombotic activity of fondaparinux is the result of ATIII-mediated selective inhibition of Factor Xa. By selectively binding to ATIII, Fondaparinux potentiates (about 300 times) the neutralization of Factor Xa by ATIII.

Is fondaparinux a factor Xa inhibitor?

Fondaparinux is a Factor Xa Inhibitor. The mechanism of action of fondaparinux is as a Factor Xa Inhibitor. In individuals with normal kidney function, fondaparinux is eliminated in urine mainly as unchanged drug. Fondaparinux sodium administered by subcutaneous injection is rapidly and completely absorbed (absolute bioavailability is 100%).

Does fondaparinux inactivate thrombin?

Fondaparinux does not inactivate thrombin (activated Factor II). According to the manufacturer, fondaparinux has no known effect on platelet function. In studies comparing fondaparinux to enoxaparin, decreases in platelet levels were observed in similar numbers of patients from both groups (2-5%) 1, 2.